PAb 1801 can be used for the specific detection of human p53 that is synthesised in the presence of p53 from other species.
| Inventor | Institute |
|---|---|
| Lawrence Banks | Cancer Research UK, London Research Institute: Lincoln's Inn Fields |
| SKU: | 151144 |
|---|---|
| Product description: | PAb 1801 can be used for the specific detection of human p53 that is synthesised in the presence of p53 from other species. |
| Alternate name: | Mouse monoclonal P53 antibody |
| Conjugation: | Unconjugated |
| Isotype: | IgG1 |
| Molecular weight: | 53 kDa |
| Immunogen: | Purified p53-b-galactosidase fusion proteins |
| Myeloma used: | P3/NS1/1-Ag4.1 |
| Cat. #: | 151144 |
|---|---|
| Provenance and Ownership: | The Anti-p53 [Pab 1801] is owned by Cancer Research UK. CancerTools supplies the Anti-p53 [Pab 1801] under licence from Cancer Research UK and is the authorised source for its distribution. Sourcing Anti-p53 [Pab 1801] directly from the IP owner ensures authenticity, provenance and compliance with all applicable licensing and research use requirements. |
| Tool sub type: | Primary antibody |
| Unit size: | 100 ug |
| Cancer types: | Other |
| Research Fields: | Apoptosis and autophagy; Cancer; Cell biology; Genetics |
| Application: | ChIP ; ELISA ; FACS ; IHC ; IF ; IP ; RIA ; WB |
| Target: | p53 |
| Reactivity: | Human |
| Clone: | Pab 1801 |
| Host: | Mouse |
| Class: | Monoclonal |
| Primary citation: | Banks et al. 1986. Eur J Biochem. 159(3):529-34. PMID: 2428616. |
| Target background: | p53 is a crucial tumour suppressor involved in over 50% of cancers. It acts as a stress-responsive transcription factor and plays a vital role in regulating cell cycle arrest, promoting apoptosis, maintaining genomic stability, controlling the cell cycle, and inhibiting angiogenesis. Known as the “guardian of the genome,” p53 prevents gene mutations. Mutations in the p53 gene are common in human cancers, resulting in dysfunctional proteins unable to bind to DNA. This loss of fun… |
|---|
| Format: | Liquid |
|---|---|
| Concentration: | 1 mg/ml |
| Storage buffer: | PBS with 0.02% azide |
| Storage conditions: | ‘-15° C to -25° C |
| Shipping conditions: | Dry ice |
| References: |
Beckerman et al. 2016. Cell Cycle. :1-14. PMID: 27210019. Loughery et al. 2014. Nucleic Acids Res. 42(12):7666-80. PMID: 24928858. Thomas et al. 2013. J Biol Chem. 288(11):7606-17. PMID: 23341460. Thomas et al. 2012. PLoS One. 7(5):e36447. PMID: 22590546. Masters et al. 2003. J Pathol. 200(1):74-81. PMID: 12692844. Wolff et al. 2001. Oncogene. 20(11):1307-17. PMID: 11313875. Said et al. 1992. Am J Pathol. 141(6):1343-8. PMID: 1466398. Porter et al. 1992. |
|---|
| Cat. # | Tool Name | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 151017 | Anti-MBP [R29.6] |
Key Info
Anti-MBP [R29.6]
|
View Tool | |||||||||||||||||||
| 151030 | Anti-Progesterone [11P14] |
Key Info
Anti-Progesterone [11P14]
|
View Tool | |||||||||||||||||||
| 151033 | Anti-HSVUL42 [13C9] |
Key Info
Anti-HSVUL42 [13C9]
|
View Tool | |||||||||||||||||||
| 151035 | Anti-CD8 [14] mAb |
Key Info
Anti-CD8 [14] mAb
|
View Tool | |||||||||||||||||||
| 151040 | Anti-Integrins aL, aX, aMb2 [24] |
Key Info
Anti-Integrins aL, aX, aMb2 [24]
|
View Tool | |||||||||||||||||||
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.